Studies find that ERβ acts as a tumor suppressor by inhibiting its proliferation, reduces inflammation and induces apoptosis of breast cancer cells, aiding in breast cancer therapy and being associated with better prognosis [108,109]. This evidence concerns the gene ESR2 and breast carcinoma.